Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JP9Y | ISIN: DK0060336014 | Ticker-Symbol: NZM2
Tradegate
24.04.25
20:51 Uhr
55,90 Euro
-0,10
-0,18 %
1-Jahres-Chart
NOVONESIS A/S Chart 1 Jahr
5-Tage-Chart
NOVONESIS A/S 5-Tage-Chart
RealtimeGeldBriefZeit
55,8856,1024.04.
55,9256,0624.04.

Aktuelle News zur NOVONESIS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiNovonesis (Novozymes A/S): Transactions under Novonesis' share buyback program4
14.04.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program5
07.04.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program5
04.04.Dividendenbekanntmachungen (04.04.2025)9.849 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  AMERICAN EXPRESS COMPANY  US0258161092  0,82 USD  0,742 EUR  BARCLAYS PLC  GB0031348658  0,055 GBP   EUR  BRISTOL-MYERS SQUIBB COMPANY  US1101221083  0...
► Artikel lesen
03.04.Novonesis (Novozymes A/S): Resolutions from the Annual General Meeting 2025317Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2024Approval of distribution of profit...
► Artikel lesen
31.03.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program5
26.03.Novonesis (Novozymes A/S): Trading by management and close relations of management4
NOVONESIS Aktie jetzt für 0€ handeln
24.03.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program8
17.03.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program5
13.03.Pioneering plant microbiome research: Julia Vorholt receives 2025 Novonesis Biotechnology Prize from the Novo Nordisk Foundation579COPENHAGEN, Denmark, March 13, 2025 /PRNewswire/ -- Professor Julia Vorholt's work has changed how we think about plant health. Her innovative research on plant microbiomes holds the potential...
► Artikel lesen
10.03.Novonesis (Novozymes A/S): Transactions under Novonesis' share buyback program5
07.03.Laufende Fusionskontrollverfahren: NOVOZYMES A /S, Bagsværd, Dänemark; Erwerb des Tierfutterenzyme-Geschäfts der DSM NUTRITIONAL PRODUCTS HOLDING AG, Kaiseraugst, Schweiz411Datum der Anmeldung:04.03.2025Aktenzeichen:B3-39/25Unternehmen:NOVOZYMES A/S, Bagsværd, Dänemark; Erwerb des Tierfutterenzyme-Geschäfts der DSM NUTRITIONAL PRODUCTS HOLDING AG, Kaiseraugst, SchweizProduktmärkte:Vertrieb...
► Artikel lesen
05.03.Novonesis (Novozymes A/S): Election of employee representatives to the Board of Directors17
05.03.JPMorgan raises Novonesis price target to DKK54518
05.03.Novonesis (Novozymes A/S): Initiation of share buyback program7
03.03.Novonesis (Novozymes A/S): Trading by management and close relations of management7
27.02.Novonesis (Novozymes A/S): Trading by management and close relations of management6
26.02.Novonesis A/S reports FY results54
26.02.Novonesis (Novozymes A/S): 12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025525Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of 37-38%....
► Artikel lesen
26.02.Novonesis (Novozymes A/S): 12M 2024 - Organic pro forma sales growth of 8%, with pro forma adjusted EBITDA margin of 36.1%2662024 organic pro forma sales growth of 8%, with pro forma adjusted EBITDA margin of 36.1%. 2025 outlook of 5-8% organic pro forma sales growth and 37-38% adjusted EBITDA margin. 2024 organic pro...
► Artikel lesen
Seite:  Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2